China has formally nominated senior health official Dr Song Li to contest the leadership of the World Health Organization, Foreign Ministry spokesperson Mao Ning announced on Thursday. The nomination reflects Beijing’s ambition to expand its footprint within international governing bodies, especially as the current director‑general, Tedros Adhanom Ghebreyesus, completes his second five‑year term in August and is ineligible for another run under WHO rules. The WHO’s executive board will later narrow the field to three candidates ahead of the May World Health Assembly vote, where the next chief will be chosen.
China’s strategic push in global health governance
Beijing has been actively seeking greater roles within United Nations institutions in recent years, a move that contrasts with the United States’ retreat from numerous international bodies during the Trump administration. Chinese nationals have at times headed as many as four UN agencies simultaneously, though currently only one Chinese official, Qu Dongyu, leads the Food and Agriculture Organization based in Rome. By putting forward Dr Song Li, China signals its intent to deepen involvement in global health policy and to champion multilateralism through the WHO platform.
Dr Song Li’s credentials and policy focus
Dr Song Li is a senior public health official whose career has intersected with some of the most pressing health crises of the past decade. She played an active role during the COVID‑19 pandemic and the earlier SARS outbreak, and her expertise encompasses maternal and child health policies as well as international cooperation. According to her official biography, Dr Song has been instrumental in shaping China’s response strategies and in fostering collaborative efforts across borders. “China’s nomination of Dr Song Li to run for the position reflects China’s willingness to work with all parties to jointly promote the building of a community of health for all humanity, and demonstrates China’s firm support for multilateralism and the WHO,” spokesperson Mao Ning said.

Competing candidates and the selection process
The WHO director‑general race now features a diverse pool of contenders. Officially announced candidates include Dr Hanan Mohammed Al‑Kuwari of Qatar, Dr Hanan Balkhy of Saudi Arabia, Dr Hans Kluge of Belgium, Dr María Neira of Spain, Indonesia’s Budi Gunadi Sadikin, and Dr Gevorg Tamamyan of Botswana. Countries were required to submit their nominations by 24 September, though public announcements can follow later. The WHO’s executive board, meeting in late January and early February, will review the field and reduce it to three finalists for consideration by member states at the World Health Assembly in May, where the final election will take place.
Implications for multilateral health cooperation
The contest for the WHO’s top job comes at a critical juncture for global health. The organization is still navigating the aftermath of the COVID‑19 pandemic, addressing ongoing challenges such as emerging infectious diseases, health system resilience, and equitable access to vaccines. A candidate from China introduces a new dynamic, potentially reshaping the balance of influence within the agency and influencing future policy directions on issues ranging from pandemic preparedness to health‑related sustainable development goals. Observers note that the outcome will not only affect the WHO’s leadership style but also signal broader trends in international cooperation and the evolving role of major powers in shaping global health governance.

Why it Matters
The nomination of Dr Song Li underscores a strategic shift in China’s engagement with multilateral institutions, marking a concerted effort to elevate its voice in world health affairs. As the WHO faces mounting pressures—from new health threats to calls for reform—Beijing’s candidacy could recalibrate the power dynamics within the organization and influence the direction of global health policy for years to come. This development is therefore pivotal not only for the future of the WHO but also for the broader architecture of international cooperation in health.
